This study compares disease free survival rate in patients treated with durvalumab after surgery versus observation only with early-stage non-small cell lung cancer.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Non-Small Cell Lung
Webform